- Q1 2024 Chromadex Corp Earnings Call TranscriptMay 08, 2024$3.83 (+2.13%)Earnings
- Q4 2023 Chromadex Corp Earnings Call TranscriptMar 06, 2024$1.74 (+0.58%)Earnings
- Q3 2023 Chromadex Corp Earnings Call TranscriptNov 08, 2023$1.6 (+4.58%)Earnings
- Q2 2023 Chromadex Corp Earnings Call TranscriptAug 09, 2023$1.65 (-0.60%)Earnings
- Chromadex Corp at LD Micro Invitational Conference TranscriptJun 06, 2023
- Q1 2023 Chromadex Corp Earnings Call TranscriptMay 10, 2023$1.47 (+6.14%)Earnings
- Q4 2022 Chromadex Corp Earnings Call TranscriptMar 08, 2023$1.83 (+12.96%)Earnings
- Q3 2022 Chromadex Corp Earnings Call TranscriptNov 02, 2022$1.67 (+1.83%)Earnings
- Q2 2022 Chromadex Corp Earnings Call TranscriptAug 10, 2022$2.06 (+7.29%)Earnings
- Chromadex Corp KOL Webinar on the Transforming Benefits of Nicotinamide Riboside (NR) TranscriptJul 20, 2022
- Q1 2022 Chromadex Corp Earnings Call TranscriptMay 12, 2022$1.64 (+0.61%)Earnings
- Q4 2021 Chromadex Corp Earnings Call TranscriptMar 09, 2022$2.72 (+4.62%)Earnings
- Q3 2021 Chromadex Corp Earnings Call TranscriptNov 03, 2021$6.55 (+2.18%)Earnings
- Q2 2021 Chromadex Corp Earnings Call TranscriptAug 03, 2021$8.73 (-2.13%)Earnings
- Q1 2021 Chromadex Corp Earnings Call TranscriptMay 06, 2021$8.58 (-3.92%)Earnings
- Q4 2020 Chromadex Corp Earnings Call TranscriptMar 10, 2021$10.75 (-6.20%)Earnings
- Q3 2020 Chromadex Corp Earnings Call TranscriptNov 04, 2020$4.78 (+1.49%)Earnings
- Q2 2020 Chromadex Corp Earnings Call TranscriptAug 06, 2020$4.92 (-4.28%)Earnings
- Q1 2020 Chromadex Corp Earnings Call TranscriptMay 11, 2020$5.46Earnings
- Q4 2019 Chromadex Corp Earnings Call TranscriptMar 10, 2020$3.43 (-2.28%)Earnings
- Q3 2019 Chromadex Corp Earnings Call TranscriptNov 12, 2019$2.83 (-0.70%)Earnings
- Q2 2019 Chromadex Corp Earnings Call TranscriptAug 07, 2019$4.37 (-2.24%)Earnings
- Q1 2019 Chromadex Corp Earnings Call TranscriptMay 09, 2019$4.74 (+1.94%)Earnings
- Q4 2018 Chromadex Corp Earnings Call TranscriptMar 07, 2019$3.43 (-1.44%)Earnings
Chromadex Corp KOL Webinar on the Transforming Benefits of Nicotinamide Riboside (NR) Transcript
Good morning, and welcome to the ChromaDex KOL Webinar. (Operator Instructions) This call is being recorded and a replay will be made available on the ChromaDex website following the conclusion of the event. I'd now like to turn the call over to your host, Robert Fried, Chief Executive Officer of ChromaDex. Please go ahead, Robert.
Thank you so much. Good morning, everyone, and thank you for joining us on today's KOL webinar on the transformational benefits of nicotinamide riboside, also referred to as NR or Niagen for short.
For those of you whom I've not had the pleasure of meeting, it's nice to meet you. My name is Rob Fried, and I'm the CEO of ChromaDex. ChromaDex is the leading bioscience company dedicated to healthy aging and research on the many benefits of nicotinamide riboside, which is by far the most efficient precursor to nicotinamide adenine dinucleotide or NAD.
NAD is the mission-critical coenzyme to cellular metabolism and declines naturally as we age.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)